ALLO vs DHI · rev $4.6M vs P/E 9.6, rev $34.25B
Allogene Therapeutics Inc (ALLO) versus DR Horton Inc (DHI) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
DR Horton Inc (DHI) is a residential construction company listed on US.
Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
ALLO currently screens at market cap $258.1M. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Not investment advice. Open the ALLO and DHI stock pages for the full models.
Not investment advice.